Effectiveness of Reminiscence Therapy Versus Cognitive Stimulation in Older Adults With Cognitive Decline: a Quasi-experimental Pilot Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 106
- 试验地点
- 2
- 主要终点
- Change in cognition (person with cognitive decline)
研究概览
简要总结
Although data suggest that non-pharmacologic therapies such as Reminiscence Therapy (RT) and Cognitive Stimulation (CS) can potentially maintain or reverse this trend, cognitive impairment can be a precursor to neurodegenerative processes. This study aimed to assess how an RT and a CS program affected cognition, depressive symptomatology, and quality of life (QoL) in older persons with cognitive decline who attended community support institutions in central Portugal. For seven weeks, a quasi-experimental study with two arms (RT and CS program) was conducted. The intervention was completed by 76 of the 109 older persons who were first screened (50 in the RT program, 26 in the CS program). In both groups, a pre- and post-intervention analysis revealed statistically significant differences in cognition, particularly in older adults' delayed recall ability.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Triple (Participant, Care Provider, Outcomes Assessor)
盲法说明
Treatment allocation will be done per institution, after a centralized randomization process. Care providers and outcome assessors will be blinded to the allocation process.
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Ability to give informed consent before study commencement;
- •Ability to participate in group activities for a period between 45 to 60 minutes;
- •No pronounced impairment of their visual and auditory abilities;
- •Mild to moderate cognitive decline, assessed as a score equal to or below 20 points in the Six-Item Cognitive Impairment Test (6-CIT).
排除标准
- •Unstable clinical condition;
- •Prescribed with cholinesterase inhibitors and/or antipsychotics during the study period.
结局指标
主要结局
Change in cognition (person with cognitive decline)
时间窗: 8 weeks post baseline
Measured using the Montreal Cognitive Assessment (MoCA). Scale scores vary between 0 and 30 points; higher scores correspond to a higher cognition level.
Change in depressive dymptomatology (person with cognitive decline)
时间窗: 8 weeks post baseline
Measured using the 10-items Geriatric Depression Scale (GDS-10). Scale scores vary between 0 and 10 points; scores equal or above 2 points correspond to a screening diagnosis of depression.
Change in quality of life (person with cognitive decline)
时间窗: Pre-intervention (baseline), 8 weeks post baseline
Measured using the World Health Organization Quality of Life - module for older adults (WHOQOL-OLD-8). Scale scores vary between 8 and 40 points; higher scores correspond to a higher level of quality of life.
次要结局
未报告次要终点
研究者
Paulo Costa
Researcher
Escola Superior de Enfermagem de Coimbra